शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEPHAARMASIA LTD.· Pharmaceuticals & BiotechnologyMinimalNeutral
Announced Mon, 12 Oct, 2026 · 11:42 IST

RTA certifies SEBI Regulation 74(5) compliance for Sep 2026 quarter

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹91.90
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%—
Pharmaceuticals peers, median of 168sector-0.1%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
-9.7
15m
-9.7
30m
-9.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—+0.8—-0.1—
Next day
—+1.0—-0.1—
2d
—+1.7—-0.3—
3d
—+0.1—-0.9—
4d
—+0.8—-0.8—
5d
—-0.9—-2.2—
1w
—-4.5—-4.5—
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Phaarmasia Ltd has submitted a Regulation 74(5) certificate from its Registrar, Venture Capital and Corporate Investments Pvt Ltd, for the quarter ending 30 Sep 2026. The RTA confirms that share certificates received for dematerialisation were mutilated and cancelled after verification, and that NSDL and CDSL were updated as the registered owners within the 15-day SEBI timeline. Details have been shared with the stock exchange. This is a routine quarterly compliance filing.

Likely market impact

Routine regulatory compliance filing. No material impact on stock price or shareholders.